Press

NORTH READING, Mass., Sept. 9, 2021– ProTom International, a leading provider of compact proton therapy technology that is transforming cancer treatment, has entered into an agreement with [...]

March, 2021 – ProTom is pleased to announce that its single-room Radiance 330® Proton Therapy System at the Gordon-Browne Proton Therapy Center at Massachusetts General Hospital (MGH) has [...]

Wakefield, Massachusetts, January 11th, 2021 – ProTom International Holding Corporation (“ProTom”) is pleased to announce that it has signed a distribution and licensing agreement with Guohong [...]

Massachusetts General Hospital (“MGH”) treated its first patient on ProTom International’s Radiance 330® Proton Therapy System (the “Radiance 330”) at the Gordon-Browne Proton Therapy Center, [...]

Wakefield, Mass., June 10, 2020 – ProTom International is pleased to announce that it will install its Radiance 330® Proton Therapy System at the new Australian Bragg Centre, Adelaide, [...]

WAKEFIELD, Mass., October 3, 2019 — ProTom International Holding Corporation (“ProTom”), a market-leading proton therapy technology manufacturer, announced that it has received 510(k) clearance [...]

Award is a reflection on ProTom’s growth and commitment to job creation and economic growth in Massachusetts For the second year in a row, ProTom International has been selected to receive [...]